Showing 1 - 2 of 2 Symptoms and General Pathology

Status: Enrolling

Investigator: Tetsuo Ashizawa

Study Coordinator: Titilayo Olubajo

Phone: 713.363.9803

The primary purpose of this study is to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in subjects with spinocerebellar ataxia (SCA). ... Read more >

Status: Open Not Enrolling

Investigator: Terry Clyburn

Study Coordinator:


This study is designed to observe the long term clinical outcomes of patient-specific knee arthroplasty in patients with osteoarthritis. ... Read more >